The Strategic Role of CDMOs in Biologics Development
In the rapidly evolving landscape of the pharmaceutical industry, biologics have emerged as a beacon of hope for treating various diseases with unprecedented precision and efficacy. These complex molecules, derived from living organisms, require a nuanced approach to development and manufacturing, setting them apart from traditional small-molecule drugs. This is...